首页 正文

Esketamine for Treatment-Resistant Depression in Pakistan: A Promising Strategy

{{output}}
Depression, projected to be the leading cause of global disability by 2030, affects up to 19.62% of Pakistan's population. Treatment-resistant depression (TRD), characterized by poor response to at least two antidepressants, poses a major clinical challenge. ... ...